Timing of Antiplatelet and Anticoagulant Therapy Resumption Following Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis.

Gastrointestinal bleeding is a major complication in patients receiving antithrombotic therapy.

This meta-analysis aimed to quantify the risks and benefits of antithrombotic therapy resumption vs discontinuation following gastrointestinal bleeding, and to evaluate the impact of resumption timing on recurrent gastrointestinal bleeding, major vascular events, and all-cause mortality.